Table 3.
Mean ± SD of the scores of multiple sclerosis QoL subscales after and before the intervention among the groups.
Variables | AT + Vit D | AT | Vit D | C | P-valuea |
---|---|---|---|---|---|
Physical health | |||||
Before | 39.13 ± 1.43 | 39.32 ± 2.23 | 38.90 ± 2.10 | 38.85 ± 2.32 | |
After | 49.04 ± 2.17 | 46.14 ± 1.35 | 41.32 ± 1.54 | 37.06 ± 1.60 | |
P† | 0.001* | 0.001* | 0.031* | 0.087 | |
Δ | 9.91 ± 0.74 μ€β | 6.82 ± 0.88€β | 2.42 ± 0.56β | −1.79 ± 0.72€β | 0.001¥ |
Role limitations due to physical problems | |||||
Before | 31.67 ± 2.15 | 32.13 ± 2.11 | 31.95 ± 3.01 | 32.32 ± 1.73 | |
After | 43.21 ± 3.17 | 40.18 ± 1.93 | 36.14 ± 1.19β | 31.73 ± 1.26 | |
P† | 0.001* | 0.023* | 0.039* | 0.214 | |
Δ | 11.54 ± 1.02 μ€β | 8.05 ± 0.18€β | 4.19 ± 1.82β | −0.59 ± 0.74 | 0.001¥ |
Role limitations due to emotional problems | |||||
Before | 35.23 ± 1.12 | 36.22 ± 2.41 | 35.97 ± 3.07 | 36.04 ± 1.57 | |
After | 53.36 ± 1.45 | 48.65 ± 2.36 | 39.55 ± 1.24 | 35.21 ± 1.42 | |
P† | 0.001* | 0.001* | 0.034* | 0.471 | |
Δ | 18.13 ± 0.33 μ€β | 12.43 ± 0.05€β | 3.58 ± 1.83β | −0.83 ± 0.15 | 0.001¥ |
Pain | |||||
Before | 65.42 ± 1.26 | 66.03 ± 1.31 | 65.76 ± 2.09 | 66.20 ± 2.13 | |
After | 74.36 ± 2.01 | 69.37 ± 2.19 | 67.25 ± 1.26 | 65.18 ± 1.39 | |
P† | 0.001* | 0.035* | 0.049* | 0.327 | |
Δ | 8.94 ± 0.75 μ€β | 3.34 ± 0.88€β | 1.49 ± 0.83β | −1.02 ± 0.74 | 0.001¥ |
Emotional well being | |||||
Before | 41.54 ± 1.19 | 41.12 ± 2.25 | 40.95 ± 2.16 | 42.33 ± 1.70 | |
After | 49.18 ± 2.11 | 46.13 ± 2.48 | 43.14 ± 1.44 | 42.04 ± 0.98 | |
P† | 0.001* | 0.017* | 0.028* | 0.514 | |
Δ | 7.64 ± 0.92 μ€β | 5.01 ± 0.23€β | 2.19 ± 0.72β | −0.29 ± 0.72 | 0.001¥ |
Energy | |||||
Before | 30.56 ± 1.42 | 31.26 ± 2.65 | 30.88 ± 2.15 | 31.84 ± 1.38 | |
After | 38.06 ± 2.24 | 36.77 ± 1.83 | 33.27 ± 1.46 | 30.09 ± 0.78 | |
P† | 0.001* | 0.001* | 0.037* | 0.491 | |
Δ | 7.5 ± 0.82€β | 5.51 ± 0.82€β | 2.39 ± 0.69β | 1.75 ± 0.6 | 0.001¥ |
Health perception | |||||
Before | 42.56 ± 2.08 | 43.13 ± 1.76 | 43.34 ± 1.96 | 42.33 ± 2.11 | |
After | 51.12 ± 1.67 | 50.16 ± 1.78 | 47.10 ± 1.21 | 42.08 ± 1.04 | |
P† | 0.001* | 0.001* | 0.021* | 0.647 | |
Δ | 8.56 ± 0.41€β | 7.03 ± 0.02€β | 3.76 ± 0.75β | −0.25 ± 1.07 | 0.001¥ |
Social function | |||||
Before | 60.44 ± 1.23 | 61.11 ± 2.76 | 61.32 ± 3.04 | 60.88 ± 2.13 | |
After | 67.20 ± 1.46 | 65.27 ± 1.29 | 63.15 ± 1.36 | 60.55 ± 1.39 | |
P† | 0.001* | 0.015* | 0.029* | 0.723 | |
Δ | 6.76 ± 0.23 μ€β | 4.16 ± 1.47€β | 1.83 ± 1.68β | −0.33 ± 0.74 | 0.001¥ |
Cognitive function | |||||
Before | 65.23 ± 1.21 | 66.17 ± 1.73 | 65.22 ± 2.06 | 66.27 ± 2.16 | |
After | 72.20 ± 1.46 | 70.04 ± 1.33 | 68.06 ± 1.05 | 66.02 ± 1.44 | |
P† | 0.001* | 0.019* | 0.034* | 0.650 | |
Δ | 6.97 ± 0.25 μ€β | 4.23 ± 0.4€β | 2.84 ± 1.01β | 0.25 ± 0.72 | 0.001¥ |
Health distress | |||||
Before | 70.32 ± 1.56 | 71.13 ± 1.21 | 70.66 ± 3.19 | 70.30 ± 2.14 | |
After | 77.36 ± 2.01 | 76.27 ± 1.29 | 73.45 ± 2.16 | 70.21 ± 2.09 | |
P† | 0.001* | 0.035* | 0.049* | 0.421 | |
Δ | 7.04 ± 0.45€β | 5.14 ± 0.08€β | 2.79 ± 1.03β | −0.09 ± 0.05 | 0.001¥ |
Sexual function | |||||
Before | 68.22 ± 2.31 | 68.76 ± 1.82 | 69.11 ± 2.34 | 69.30 ± 2.24 | |
After | 76.36 ± 2.01 | 73.27 ± 1.07 | 71.35 ± 1.34 | 69.21 ± 2.19 | |
P† | 0.001* | 0.021* | 0.044* | 0.627 | |
Δ | 8.14 ± 0.3 μ€β | 4.51 ± 0.75€β | 2.24 ± 1β | 0.09 ± 0.05 | 0.001¥ |
Change in health | |||||
Before | 43.15 ± 1.38 | 42.67 ± 2.76 | 43.04 ± 1.96 | 42.73 ± 2.33 | |
After | 47.12 ± 1.57 | 46.30 ± 1.34 | 45.10 ± 0.92β | 42.38 ± 1.24 | |
P† | 0.001* | 0.027* | 0.043* | 0.501 | |
Δ | 3.97 ± 0.19€β | 3.63 ± 1.42€β | 2.06 ± 1.04β | −0.35 ± 1.09 | 0.001¥ |
Satisfaction with sexual function | |||||
Before | 55.34 ± 2.27 | 56.16 ± 1.64 | 55.77 ± 1.40 | 56.33 ± 2.21 | |
After | 63.20 ± 1.33 | 60.22 ± 2.30 | 59.14 ± 1.51 | 55.80 ± 1.43 | |
P† | 0.001* | 0.017* | 0.036* | 0.320 | |
Δ | 7.86 ± 0.94 μ€β | 4.06 ± 0.66€β | 3.37 ± 0.11β | −0.53 ± 0.18 | 0.001¥ |
Overall QoL | |||||
Before | 54.74 ± 1.47 | 55.19 ± 1.54 | 55.47 ± 0.88 | 54.68 ± 1.20 | |
After | 59.20 ± 1.33 | 58.27 ± 2.36 | 56.13 ± 1.47 | 54.19 ± 1.59 | |
P† | 0.001* | 0.001* | 0.039* | 0.670 | |
Δ | 4.46 ± 0.14€β | 3.08 ± 0.82€β | 0.66 ± 0.59β | −0.19 ± 0.39 | 0.001¥ |
Physical health composite | |||||
Before | 48.15 ± 2.08 | 48.77 ± 2.76 | 47.14 ± 2.06 | 48.59 ± 1.50 | |
After | 57.11 ± 1.36 | 56.32 ± 2.31 | 53.16 ± 1.58 | 48.21 ± 2.23 | |
P† | 0.001* | 0.001* | 0.022* | 0.709 | |
Δ | 8.96 ± 0.72 €β | 7.55 ± 0.45€β | 6.02 ± 0.48β | −0.38 ± 0.73 | 0.001¥ |
Mental health composite | |||||
Before | 53.24 ± 1.30 | 54.17 ± 1.66 | 53.37 ± 1.43 | 54.33 ± 2.48 | |
After | 62.21 ± 1.40 | 59.73 ± 2.30 | 57.12 ± 1.49 | 53.80 ± 1.43 | |
P† | 0.001* | 0.027* | 0.034* | 0.420 | |
Δ | 8.97 ± 0.1 μ€β | 5.56 ± 0.64€β | 3.75 ± 0.06β | −0.53 ± 1.05 | 0.001¥ |
AT + Vit D: aerobic training + vitamin D supplement; AT: aerobic training group; Vit D: vitamin D supplement group; C: the control group. *Data analysis was done by the analysis of one-way analysis of variance test followed by post hoc Tukey's test; P†: Statistical analysis was done by paired sample t-test. *: Significantly different in comparison pre- and post within the groups. ¥: Significantly different comparing Δ between groups. μ: Significantly different comparing with AT. €: Significantly different comparing with Vit D. β: Significantly different comparing with C.